KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) R&D In Process (2016 - 2023)

Johnson & Johnson (JNJ) has disclosed R&D In Process for 13 consecutive years, with $49.0 million as the latest value for Q2 2023.

  • Quarterly R&D In Process fell 91.97% to $49.0 million in Q2 2023 from the year-ago period, while the trailing twelve-month figure was $222.0 million through Apr 2023, down 85.3% year-over-year, with the annual reading at $783.0 million for FY2023, 13.0% down from the prior year.
  • R&D In Process hit $49.0 million in Q2 2023 for Johnson & Johnson, down from $173.0 million in the prior quarter.
  • In the past five years, R&D In Process ranged from a high of $900.0 million in Q4 2021 to a low of $6.0 million in Q2 2020.
  • Historically, R&D In Process has averaged $350.4 million across 5 years, with a median of $155.5 million in 2020.
  • Biggest five-year swings in R&D In Process: surged 552.17% in 2021 and later tumbled 91.97% in 2023.
  • Year by year, R&D In Process stood at $890.0 million in 2019, then crashed by 84.49% to $138.0 million in 2020, then soared by 552.17% to $900.0 million in 2021, then crashed by 32.22% to $610.0 million in 2022, then plummeted by 91.97% to $49.0 million in 2023.
  • Business Quant data shows R&D In Process for JNJ at $49.0 million in Q2 2023, $173.0 million in Q1 2023, and $610.0 million in Q2 2022.